BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Novartis
Colorcon
McKinsey
Cipla
Argus Health
US Department of Justice
Cantor Fitzgerald
Mallinckrodt
Daiichi Sankyo

Generated: January 21, 2018

DrugPatentWatch Database Preview

NEOSTIGMINE METHYLSULFATE Drug Profile

« Back to Dashboard

When do Neostigmine Methylsulfate patents expire, and when can generic versions of Neostigmine Methylsulfate launch?

Neostigmine Methylsulfate is a drug marketed by Amphastar Pharms Inc, Eurohlth Intl Sarl, Fresenius Kabi Usa, and Par Sterile Products. and is included in four NDAs.

The generic ingredient in NEOSTIGMINE METHYLSULFATE is neostigmine methylsulfate. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the neostigmine methylsulfate profile page.
Drug patent expirations by year for NEOSTIGMINE METHYLSULFATE
Pharmacology for NEOSTIGMINE METHYLSULFATE
Medical Subject Heading (MeSH) Categories for NEOSTIGMINE METHYLSULFATE

US Patents and Regulatory Information for NEOSTIGMINE METHYLSULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharms Inc NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209933-001 Sep 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Sterile Products NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 208405-001 Apr 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Eurohlth Intl Sarl NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 207042-002 Dec 28, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Sterile Products NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 208405-002 Apr 26, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amphastar Pharms Inc NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209933-002 Sep 25, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Eurohlth Intl Sarl NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 207042-001 Dec 28, 2015 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 203629-002 Jan 8, 2015 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 203629-001 Jan 8, 2015 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
US Army
Deloitte
Farmers Insurance
Accenture
Fuji
McKinsey
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot